SCHEMBL1328801

SCHEMBL1328801

COC(=O)c1ccc(C#Cc2ccnc3[nH]ccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
NUDT1 P36639 1/20 0.45
PTPN11 Q06124 1/20 0.44
IKBKB O14920 1/20 0.42
CHUK O15111 1/20 0.42
ROCK2 O75116 3/20 0.40
ROCK1 Q13464 2/20 0.40
CIT O14578 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
PRKCB P05771 1/20 0.40
PRKCA P17252 1/20 0.40
PRKACA P17612 1/20 0.40
CSNK2A2 P19784 1/20 0.40
MARK3 P27448 1/20 0.40
BMPR1A P36894 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CLK1 P49759 1/20 0.40
GSK3A P49840 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1329286 0.86 CDK8 (0.46) KDM4EALDH1A1NUDT1ROCK2ROCK1
SCHEMBL1328384 0.82 NUDT1 (0.44) NUDT1CITAAK1MAP2K1AXL
SCHEMBL858643 0.82 TTBK1 (0.46) NUDT1IKBKBCHUKROCK2ROCK1
SCHEMBL1328241 0.81 JAK3 (0.43) NUDT1IKBKBCHUKROCK2ROCK1
SCHEMBL1329895 0.80 NUDT1 (0.48) KDM4ENUDT1IKBKBCHUKROCK1
SCHEMBL1328582 0.80 KDM4E (0.55) KDM4EALDH1A1CIT
SCHEMBL1328009 0.80 PRKCI (0.44) NUDT1IKBKBCHUKROCK1CIT
SCHEMBL1328714 0.79 FFAR1 (0.42) NUDT1IKBKBCHUKROCK1CIT
SCHEMBL1329976 0.77 PRKCI (0.44) NUDT1IKBKBCHUKROCK1CIT
SCHEMBL12125812 0.77 PRKCI (0.44) NUDT1IKBKBCHUKROCK1PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110282056-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-11-17 US claimed
EP-2231282-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF Merck Patent GmbH (DE) 2010-09-29 EP claimed
WO-2009094123-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-07-30 WO claimed
US-20110282056-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110282056-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP3K19, MAP3K20, MAP3K1 KDM4E 1543/4885ALDH1A1 3339/4885NUDT1 3161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.